M&T Bank’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-1
Closed -$1K 1761
2016
Q2
$1K Buy
+1
New +$69 ﹤0.01% 1684
2015
Q1
Sell
-2,455
Closed -$1K 2137
2014
Q4
$1K Hold
2,455
﹤0.01% 2107
2014
Q3
$6K Buy
+2,455
New +$199K ﹤0.01% 2211

Other funds holding NVS

M&T Bank's NVS Position: Q1 2026 in Review

M&T Bank increased its Novartis (NVS) stake by 12% in Q1 2026, buying an estimated $2.8M and bringing the position to 171,848 shares worth $26.2M. The position accounts for 0.09% of the portfolio, ranked #170.

M&T Bank first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $30M in Q1 2015. 1,592 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • M&T Bank held 171,848 shares of Novartis worth $26.2M as of Q1 2026.
  • M&T Bank bought 18,264 Novartis shares in Q1 2026, an estimated $2.8M.
  • Novartis made up 0.09% of M&T Bank's portfolio in Q1 2026, its #170 holding.
  • M&T Bank first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
  • M&T Bank's Novartis position peaked at $30M in Q1 2015.
  • 1,592 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.